Cost Based Analysis

MDCL’s algorithmic expansion pack allows vast sets of data to be rapidly analysed and useful information extracted.

MDCL is working with its partners to correlate Quality of Life (QOL) metrics with pharmaceutical products to relate treatments to outcome.  The can show incredibly that more cost effective drugs may actually produce better outcome for patients of matching socio-economic, age and geographical locations.